Cannabis smoking impairs driving performance on the simulator and real driving: a randomized, double-blind, placebo-controlled, crossover trial

被引:30
|
作者
Micallef, Joelle [1 ,2 ,3 ]
Dupouey, Julien [1 ,2 ,3 ]
Jouve, Elisabeth [1 ,2 ,3 ]
Truillet, Romain [1 ,2 ,3 ]
Lacarelle, Bruno [4 ]
Taillard, Jacques [5 ]
Daurat, Agnes [6 ]
Authie, Colas [7 ]
Blin, Olivier [1 ,2 ,3 ]
Rascol, Olivier [8 ,9 ,10 ]
Philip, Pierre [5 ]
Mestre, Daniel [11 ]
机构
[1] AP HM, Serv Pharmacol Clin & Pharmacovigilance, 264 Rue St Pierre, F-13385 Marseille, France
[2] AP HM, CIC CPCET, 264 Rue St Pierre, F-13385 Marseille, France
[3] Aix Marseille Univ, Fac Med, INS Inst Neurosci Syst, INSERM,UMR Marseille 1106, Marseille, France
[4] AP HM, Lab Pharmacocinet, Marseille, France
[5] Univ Bordeaux, Sommeil Attent & Neuropsychiat, CNRS, USR 3413, Bordeaux, France
[6] Univ Toulouse II, CLLE LTC, EPHE, CNRS,UMR 5263, F-5263 Toulouse, France
[7] UPMC, INSERM, Inst Vis, CNRS,UMR 7210, Paris, France
[8] Univ Hosp, Dept Clin Pharmacol & Neurosci, Clin Invest Ctr, INSERM,CIC1436, Toulouse, France
[9] Univ Hosp, Clin Spatiale MEDES, Toulouse, France
[10] Univ Toulouse3, Toulouse, France
[11] Aix Marseille Univ, Inst Sci Mouvement, CNRS, UMR 7287, Marseille, France
关键词
cannabis; driving performance; driving simulation; drug effect; lateral control; ON-THE-ROAD; ALCOHOL; PHARMACOKINETICS; MARIJUANA; PERSONALITY; RELIABILITY; EXPERIENCE; SLEEPINESS; FATIGUE; BATTERY;
D O I
10.1111/fcp.12382
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Driving experiments in real conditions are considered as a gold standard' to evaluate the effects of drugs on driving performance. Several constraints are difficult to manage in these conditions, so driving simulation appears as the best alternative. A preliminary comparison is crucial before being able to use driving simulation as a valid evaluation method. The aim of this study was to design a driving simulation method for assessing drug effects on driving. We used cannabis (THC) as a positive control and assessed whether THC affects driving performance in simulation conditions and whether these effects are consistent with performance in real driving conditions. A double-blind, placebo-controlled, two successive two-way crossover design was performed using cigarettes containing 20mg of THC. Healthy occasional users of THC, aged 25-35years, who had a consistent driving experience were included. The first two sessions were realized in simulation conditions, and the last two sessions were in real driving conditions. Driving performance was estimated through inappropriate line crossings (ILC) and the standard deviation of the vehicle's lateral position. Participants felt significantly drowsier and more tired after THC, whatever the driving condition. Driving stability was significantly impaired after THC, both in simulated and real driving conditions. We also found that ILC were significantly more numerous in driving simulation conditions, as compared to real driving. In conclusion, the driving simulator was proven to be more sensitive for demonstrating THC-induced effects on driving performances. Driving simulation appears to be a good qualitative predictor of driving safety after drug intake.
引用
收藏
页码:558 / 570
页数:13
相关论文
共 50 条
  • [1] Cannabis-Impaired Driving: Insights From a Randomized, Placebo-Controlled, Double-Blind Driving Simulator Study
    Meda, Shashwath
    Stevens, Michael
    Boer, Erwin
    Ward, Nicholas
    Fernandez, Nina
    Pearlson, Godfrey
    [J]. NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 456 - 456
  • [2] Modafinil Improves Real Driving Performance in Patients with Hypersomnia: A Randomized Double-Blind Placebo-Controlled Crossover Clinical Trial
    Philip, Pierre
    Chaufton, Cyril
    Taillard, Jacques
    Capelli, Aurore
    Coste, Olivier
    Leger, Damien
    Moore, Nicholas
    Sagaspe, Patricia
    [J]. SLEEP, 2014, 37 (03) : 483 - 487
  • [3] Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial
    Philip, P.
    Chaufton, C.
    Taillard, J.
    Capelli, A.
    Coste, O.
    Leger, D.
    Moore, N.
    Sagaspe, P.
    [J]. JOURNAL OF SLEEP RESEARCH, 2014, 23 : 33 - 33
  • [4] RIFAXIMIN IMPROVES DRIVING SIMULATOR PERFORMANCE IN MINIMAL HEPATIC ENCEPHALOPATHY: A DOUBLE-BLIND, PLACEBO-CONTROLLED, PROSPECTIVE RANDOMIZED TRIAL
    Bajaj, Jasmohan S.
    Heuman, Douglas M.
    Saeian, Kia
    Hafeezullah, Muhammad
    Bell, Debulon E.
    Sterling, Richard K.
    Stravitz, R. Todd
    Wegelin, Jacob A.
    White, Melanie
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2010, 52 (04) : 330A - 330A
  • [5] Vaporized cannabis versus placebo for the acute treatment of migraine: a randomized, double-blind, placebo-controlled, crossover trial
    Schuster, Nathaniel
    Wallace, Mark
    Buse, Dawn
    Lee, Euyhyun
    Liu, Lin
    Marcotte, Thomas
    Sexton, Michelle
    [J]. CEPHALALGIA, 2023, 43 (1supp) : 23 - 24
  • [6] The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol
    Zamarripa, C. Austin
    Novak, Matthew D.
    Weerts, Elise M.
    Vandrey, Ryan
    Spindle, Tory R.
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: A randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm
    Biederman, Joseph
    Fried, Ronna
    Hammerness, Paul
    Surman, Craig
    Mehler, Bruce
    Petty, Carter R.
    Faraone, Stephen V.
    Miller, Carolyn
    Bourgeois, Michelle
    Meller, Benjamin
    Godfrey, Kathryn M.
    Reimer, Bryan
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2012, 46 (04) : 484 - 491
  • [8] Effects of fexofenadine, diphenhydramine, and alcohol on driving performance - A randomized, placebo-controlled trial in the Iowa Driving Simulator
    Weiler, JM
    Bloomfield, JR
    Woodworth, GG
    Grant, AR
    Layton, TA
    Brown, TL
    McKenzie, DR
    Baker, TW
    Watson, GS
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (05) : 354 - +
  • [9] Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial
    Levin, Frances R.
    Mariani, John J.
    Brooks, Daniel J.
    Pavlicova, Martina
    Cheng, Wendy
    Nunes, Edward V.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2011, 116 (1-3) : 142 - 150
  • [10] Effect of Ivabradine, a Novel Antianginal Agent, on Driving Performance A Randomized, Double-Blind, Placebo-Controlled Trial in Healthy Volunteers
    Macher, Jean-Paul
    Levy, Samuel
    [J]. CLINICAL DRUG INVESTIGATION, 2009, 29 (05) : 339 - 348